Kaketsuken Suspends Shipments of 12 Products Due to Modifications of Approved Manufacturing Procedures

June 9, 2015
The Ministry of Health, Labor and Welfare (MHLW) announced on June 5 that 12 plasma pheresis products manufactured by the Chemo-Sero-Therapeutic Research Institute (Kaketsuken) from blood donated in Japan were manufactured using methods that differ from those approved. According to...read more